Germline mutations in MDS/AML predisposition disorders
- PMID: 33394724
- DOI: 10.1097/MOH.0000000000000633
Germline mutations in MDS/AML predisposition disorders
Abstract
Purpose of review: Recognition of hereditary hematopoietic malignancies impacts patient management as well as health surveillance strategies for the patient and relatives who share the causative DNA variant. In this review, barriers to the diagnosis and management of patients are outlined.
Recent findings: Increasingly, individuals are being recognized as having germline predisposition to hematopoietic malignancies. Clinical testing for these syndromes is difficult for most clinicians given the need to send true germline samples and the lack of standardization in the field with regard to which genes are covered and the types of DNA changes detected. Additional barriers such as insurance coverage, especially for older individuals, and access to clinical experts need to be overcome in the future.
Summary: New research addressing whether use of hematopoietic stem cells with deleterious variants are permissive to transplantation; effective means of delivering genetic counseling and results disclosure to decrease the psychological impact of these diagnoses; and a comprehensive list of all predisposition genes will advance our ability to provide the best treatment possible for our patients and facilitate strategies to maintain excellent health throughout their lifetimes and for members of younger generations.
Video abstract: Submitted, http://links.lww.com/COH/A22.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Galera P, Dulau-Florea A, Calvo KR. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia. Int J Lab Hematol 2019; 41: (Suppl 1): 131–141.
-
- Rafei H, DiNardo CD. Hereditary myeloid malignancies. Best Pract Res Clin Haematol 2019; 32:163–176.
-
- Gocho Y, Yang JJ. Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia. Blood 2019; 134:793–797.
-
- Weinberg OK, Kuo F, Calvo KR. Germline predisposition to hematolymphoid neoplasia. Am J Clin Pathol 2019; 152:258–276.
-
- Roloff GW, Godley LA, Drazer MW. Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies. Genet Med 2020; doi: 10.1038/s41436-020-0934-y. in press. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
